Tenofovir alafenamide - Generic Drug Details
✉ Email this page to a colleague
Recent Clinical Trials for tenofovir alafenamide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chiang Mai University, Thailand | Phase 3 |
Assistance Publique - Hôpitaux de Paris, FRANCE | Phase 3 |
Ministry of Health, Thailand | Phase 3 |
Generic filers with tentative approvals for TENOFOVIR ALAFENAMIDE
Applicant | Application No. | Strength | Dosage Form |
⤷ Try a Trial | ⤷ Try a Trial | 25MG | TABLET;ORAL |
⤷ Try a Trial | ⤷ Try a Trial | EQ 25MG BASE | TABLET;ORAL |
⤷ Try a Trial | ⤷ Try a Trial | 25MG | TABLET;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.